You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
AstraZeneca
McKinsey
Boehringer Ingelheim

Last Updated: April 15, 2021

DrugPatentWatch Database Preview

ELSPAR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for ELSPAR

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of WashingtonPhase 2
Jazz PharmaceuticalsPhase 2
Dana-Farber Cancer InstitutePhase 2

See all ELSPAR clinical trials

Recent Litigation for ELSPAR

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Highland Capital Management, L.P. v. Dondero2021-01-21
Ravgen, Inc. v. Progenity, Inc.2020-12-20
Ravgen, Inc. v. Myriad Genetics, Inc.2020-12-20

See all ELSPAR litigation

PTAB Litigation
PetitionerDate
2017-11-17
2016-09-09
2013-01-28

See all ELSPAR litigation

Patent Text Search: US Patents for ELSPAR

These patents were identified by searching patent claims

Supplementary Protection Certificates for ELSPAR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2007C/027 Belgium   Start Trial PRODUCT NAME: PERFLUTREN; AUTHORISATION NUMBER AND DATE: EU/1/06/361/001 20060922
C960031 Netherlands   Start Trial PRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621
91325 Luxembourg   Start Trial PRODUCT NMAE. LUMINITY; REGISTRATION DATE: 20060920
960031 Netherlands   Start Trial 960031, 20101020, EXPIRES: 20110620
96C0047 Belgium   Start Trial PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
132007901505158 Italy   Start Trial PRODUCT NAME: MICROSFERE LIPIDICHE CONTENENTI PERFLUTRENO(LUMINITY); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/06/361/001, 20060920
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Moodys
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.